292 related articles for article (PubMed ID: 33388372)
1. Microneedles for Extended Transdermal Therapeutics: A Route to Advanced Healthcare.
Pahal S; Badnikar K; Ghate V; Bhutani U; Nayak MM; Subramanyam DN; Vemula PK
Eur J Pharm Biopharm; 2021 Feb; 159():151-169. PubMed ID: 33388372
[TBL] [Abstract][Full Text] [Related]
2. Microneedle array systems for long-acting drug delivery.
Vora LK; Moffatt K; Tekko IA; Paredes AJ; Volpe-Zanutto F; Mishra D; Peng K; Raj Singh Thakur R; Donnelly RF
Eur J Pharm Biopharm; 2021 Feb; 159():44-76. PubMed ID: 33359666
[TBL] [Abstract][Full Text] [Related]
3. Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery.
Sadeqi A; Kiaee G; Zeng W; Rezaei Nejad H; Sonkusale S
Sci Rep; 2022 Feb; 12(1):1853. PubMed ID: 35115643
[TBL] [Abstract][Full Text] [Related]
4. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
Shah V; Choudhury BK
AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
[TBL] [Abstract][Full Text] [Related]
5. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
Rastogi V; Yadav P; Husain A; Verma A
Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
[TBL] [Abstract][Full Text] [Related]
6. Current trends in polymer microneedle for transdermal drug delivery.
Ahmed Saeed Al-Japairai K; Mahmood S; Hamed Almurisi S; Reddy Venugopal J; Rebhi Hilles A; Azmana M; Raman S
Int J Pharm; 2020 Sep; 587():119673. PubMed ID: 32739388
[TBL] [Abstract][Full Text] [Related]
7. Polymeric microneedles for controlled transdermal drug delivery.
Singh P; Carrier A; Chen Y; Lin S; Wang J; Cui S; Zhang X
J Control Release; 2019 Dec; 315():97-113. PubMed ID: 31644938
[TBL] [Abstract][Full Text] [Related]
8. Poly (vinyl alcohol) microneedles: Fabrication, characterization, and application for transdermal drug delivery of doxorubicin.
Nguyen HX; Bozorg BD; Kim Y; Wieber A; Birk G; Lubda D; Banga AK
Eur J Pharm Biopharm; 2018 Aug; 129():88-103. PubMed ID: 29800617
[TBL] [Abstract][Full Text] [Related]
9. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin.
Kim M; Jung B; Park JH
Biomaterials; 2012 Jan; 33(2):668-78. PubMed ID: 22000788
[TBL] [Abstract][Full Text] [Related]
10. Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing.
Rajabi M; Roxhed N; Shafagh RZ; Haraldson T; Fischer AC; Wijngaart WV; Stemme G; Niklaus F
PLoS One; 2016; 11(12):e0166330. PubMed ID: 27935976
[TBL] [Abstract][Full Text] [Related]
11. Tissue Interlocking Dissolving Microneedles for Accurate and Efficient Transdermal Delivery of Biomolecules.
Fakhraei Lahiji S; Kim Y; Kang G; Kim S; Lee S; Jung H
Sci Rep; 2019 May; 9(1):7886. PubMed ID: 31133711
[TBL] [Abstract][Full Text] [Related]
12. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.
Hong X; Wei L; Wu F; Wu Z; Chen L; Liu Z; Yuan W
Drug Des Devel Ther; 2013; 7():945-52. PubMed ID: 24039404
[TBL] [Abstract][Full Text] [Related]
13. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.
Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF
Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650
[TBL] [Abstract][Full Text] [Related]
14. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
[TBL] [Abstract][Full Text] [Related]
15. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
[TBL] [Abstract][Full Text] [Related]
16. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
Cahill EM; O'Cearbhaill ED
Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
[TBL] [Abstract][Full Text] [Related]
17. Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches.
Karve T; Dandekar A; Agrahari V; Melissa Peet M; Banga AK; Doncel GF
Adv Drug Deliv Rev; 2024 Jul; 210():115326. PubMed ID: 38692457
[TBL] [Abstract][Full Text] [Related]
18. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
[TBL] [Abstract][Full Text] [Related]
19. 3D printed microneedles for insulin skin delivery.
Pere CPP; Economidou SN; Lall G; Ziraud C; Boateng JS; Alexander BD; Lamprou DA; Douroumis D
Int J Pharm; 2018 Jun; 544(2):425-432. PubMed ID: 29555437
[TBL] [Abstract][Full Text] [Related]
20. Advances of microneedles in hormone delivery.
Nguyen TT; Nguyen TTD; Tran NM; Vo GV
Biomed Pharmacother; 2022 Jan; 145():112393. PubMed ID: 34773762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
